Contact Us About Study Participation
Please call us at 773-989-8313 Ext. 2 to learn more. Otherwise, indicate your interest in a particular study by selecting one of the studies listed on this page and entering the study number in the appropriate form field.
A study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults with Schizophrenia.
A study of Lu AF35700 in Patients With Treatment-Resistant Schizophrenia.
A study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder.
A study to Assess the Efficacy and Safety of ITI-007 Adjunctive to Lithium or Valproate in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder.
A study in Subjects With Recent-Onset Schizophrenia or Schizophreniform Disorder to Compare Disease Progression and Disease Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics.
A study to evaluate user comprehension of instructions for a transdermal patch to treat Schizophrenia.
A bioequivalence study comparing paliperidone palmitate extended-release IM with Invega Sustenna in subjects with Schizophrenia and Schizoaffective Disorder.